Search Within

Martin Henner Voss

  1. "Radiation Oncology, Department of"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Human Oncology and Pathogenesis Program (6)
  4. Radiation Oncology, Department of (6)
  5. Solid Tumor Oncology Division (6)
  6. Surgery (6)

More Groups

People
  1. Abraham Hakimi (6)
  2. Robert Motzer (6)
  3. Chung-Han Lee (4)
  4. Nadeem Riaz (4)
  5. Timothy Chan (4)
  6. Maria Carlo (3)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2019 (3)
  4. 2017 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer Discovery (1)
  3. European Urology Oncology (1)
  4. Nature Genetics (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Elsevier BV (1)
  4. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Meeting Abstract

    Ma, J.; del Balzo, L.; Khaleel, S. S.; Flynn, J.; Zhang, Z.; Voss, M. H.; Freeman, B.; Hakimi, A. A.; Lee, C. H.; Eichholz, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: Data from a randomized phase III trial
    Journal Article

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Sanchez, A.; Liu, M.; Nixon, B. G.; Vuong, L.; Ostrovnaya, I.; Chen, Y. B.; Reuter, V.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Integrated biomarker analysis for 412 renal cell cancer (RCC) patients (pts) treated on the phase 3 COMPARZ trial: Correlating common mutation events in PBRM1 and BAP1 with angiogenesis expression signatures and outcomes on tyrosine kinase inhibitor (TKI) therapy
    Meeting Abstract

    Voss, M. H.; Kuo, F.; Chen, D.; Marker, M.; Patel, P.; Redzematovic, A.; Riaz, N.; Chan, T. A.; Choueiri, T. K.; Hsieh, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save